In the News
Key Personnel
Resources
Contact Us
In the News
11/27/2007 -
Gendux Announces Acceptance of its ADVEXIN Marketing Authorization Application for Review by the EMEA
11/13/2007 -
Gendux and Introgen Submit First Marketing Authorization Application for ADVEXIN
4/16/2007 -
Introgen Presents ADVEXIN Biomarker Data at Major Cancer Conference
9/7/2006 -
Introgen Therapeutics and Gendux AB Announce Orphan Designation for ADVEXIN Therapy in European Union
5/9/2006 -
Gendux AB and Introgen Therapeutics File European Orphan Drug Designation for ADVEXIN
Contact Our Office
Unit 21 Block 1
Port Tunnel Business Park
Dublin 17 Ireland
Phone: +353 (0)1 894 1400
Fax: +353 (0)1 894 1401
Gendux
© Copyright 2007 Gendux Molecular Limited. All Rights Reserved.
Powered by Dot Command Center
